EP3383390A4 - Piperidinyl nociceptin receptor compounds - Google Patents
Piperidinyl nociceptin receptor compounds Download PDFInfo
- Publication number
- EP3383390A4 EP3383390A4 EP16871683.5A EP16871683A EP3383390A4 EP 3383390 A4 EP3383390 A4 EP 3383390A4 EP 16871683 A EP16871683 A EP 16871683A EP 3383390 A4 EP3383390 A4 EP 3383390A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- piperidinyl
- nociceptin receptor
- receptor compounds
- compounds
- nociceptin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562261871P | 2015-12-02 | 2015-12-02 | |
PCT/US2016/064854 WO2017096323A1 (en) | 2015-12-02 | 2016-12-02 | Piperidinyl nociceptin receptor compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3383390A1 EP3383390A1 (en) | 2018-10-10 |
EP3383390A4 true EP3383390A4 (en) | 2019-11-20 |
Family
ID=58798102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16871683.5A Pending EP3383390A4 (en) | 2015-12-02 | 2016-12-02 | Piperidinyl nociceptin receptor compounds |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3383390A4 (en) |
JP (4) | JP7011596B2 (en) |
KR (1) | KR20180094940A (en) |
CN (1) | CN108883103A (en) |
AU (3) | AU2016365400C1 (en) |
CA (1) | CA3006966A1 (en) |
IL (1) | IL259726B (en) |
WO (1) | WO2017096323A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
WO2023284833A1 (en) * | 2021-07-14 | 2023-01-19 | 宜昌人福药业有限责任公司 | Spirocyclic piperidine derivative, pharmaceutical composition thereof, preparation method therefor, and use thereof |
CN115611856B (en) * | 2021-07-14 | 2024-07-05 | 宜昌人福药业有限责任公司 | Piperidine derivative and pharmaceutical composition, preparation method and application thereof |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1254895A1 (en) * | 2000-01-20 | 2002-11-06 | Eisai Co., Ltd. | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
EP1308439A1 (en) * | 2000-08-10 | 2003-05-07 | Welfide Corporation | Proline derivatives and use thereof as drugs |
WO2004056830A1 (en) * | 2002-12-19 | 2004-07-08 | Pfizer Products Inc. | Pyrrolopyrimidine derivatives |
WO2005060947A2 (en) * | 2003-12-19 | 2005-07-07 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
WO2008060621A2 (en) * | 2006-11-17 | 2008-05-22 | Abbott Laboratories | Aminopyrrolidines as chemokine receptor antagonists |
EP2141163A1 (en) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituted thiazolidinones, their production and utilisation as medicine |
WO2011029915A1 (en) * | 2009-09-10 | 2011-03-17 | Novartis Ag | Ether derivatives of bicyclic heteroaryls |
WO2011101409A1 (en) * | 2010-02-19 | 2011-08-25 | Novartis Ag | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
WO2014157687A1 (en) * | 2013-03-29 | 2014-10-02 | 大鵬薬品工業株式会社 | 1,2,4-triazine-6-carboxamide derivative with acetamide group |
WO2014174021A1 (en) * | 2013-04-24 | 2014-10-30 | Janssen Pharmaceutica Nv | 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors for the treatment of cancer |
WO2014184069A1 (en) * | 2013-05-14 | 2014-11-20 | Nerviano Medical Sciences S.R.L. | Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
WO2015044269A1 (en) * | 2013-09-26 | 2015-04-02 | Janssen Pharmaceutica Nv | NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS |
EP2878601A1 (en) * | 2012-07-27 | 2015-06-03 | Riken | Agent for treating or controlling recurrence of acute myelogenous leukemia |
WO2016062789A1 (en) * | 2014-10-23 | 2016-04-28 | Janssen Pharmaceutica Nv | New thienopyrimidine derivatives as nik inhibitors |
WO2016062791A1 (en) * | 2014-10-23 | 2016-04-28 | Janssen Pharmaceutica Nv | New pyrazole derivatives as nik inhibitors |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT817627E (en) * | 1993-12-23 | 2005-07-29 | Lilly Co Eli | PROTEIN INHIBITORS CINASE C |
CA2226058C (en) * | 1997-01-30 | 2008-01-29 | F. Hoffmann-La Roche Ag | 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives |
KR20010085824A (en) | 1998-09-18 | 2001-09-07 | 스타르크, 카르크 | Pyrrolopyrimidines as protein kinase inhibitors |
JP3966693B2 (en) | 2000-01-20 | 2007-08-29 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Nitrogen-containing ring compounds and pharmaceutical compositions comprising them |
WO2001072751A1 (en) | 2000-03-29 | 2001-10-04 | Knoll Gesellschaft Mit Beschraenkter Haftung | Pyrrolopyrimidines as tyrosine kinase inhibitors |
WO2003064425A1 (en) * | 2002-01-28 | 2003-08-07 | Pfizer Japan Inc. | N-substituted spiropiperidine compounds as ligands for orl-1 receptor |
AU2003235912A1 (en) | 2002-05-10 | 2003-11-11 | Taisho Pharmaceutical Co., Ltd. | Spiro-ring compound |
EP1601674B1 (en) * | 2002-09-09 | 2012-08-08 | Janssen Pharmaceutica NV | Hydroxyalkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
US7354925B2 (en) | 2004-03-29 | 2008-04-08 | Pfizer Inc. | Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists |
WO2006130416A2 (en) | 2005-06-02 | 2006-12-07 | Janssen Pharmaceutica, N.V. | Novel 3-spirocyclic indolyl derivatives useful as orl-1 receptor modulators |
EP2150552B1 (en) | 2007-04-09 | 2013-01-02 | Janssen Pharmaceutica NV | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression |
US9963458B2 (en) * | 2012-12-27 | 2018-05-08 | Purdue Pharma L.P. | Indole and indoline-type piperidine compounds and uses thereof |
-
2016
- 2016-12-02 AU AU2016365400A patent/AU2016365400C1/en active Active
- 2016-12-02 CA CA3006966A patent/CA3006966A1/en active Pending
- 2016-12-02 KR KR1020187018782A patent/KR20180094940A/en active Application Filing
- 2016-12-02 EP EP16871683.5A patent/EP3383390A4/en active Pending
- 2016-12-02 CN CN201680080898.5A patent/CN108883103A/en active Pending
- 2016-12-02 JP JP2018549125A patent/JP7011596B2/en active Active
- 2016-12-02 WO PCT/US2016/064854 patent/WO2017096323A1/en active Application Filing
-
2018
- 2018-05-31 IL IL259726A patent/IL259726B/en unknown
-
2022
- 2022-01-14 JP JP2022004411A patent/JP7472175B2/en active Active
- 2022-04-29 AU AU2022202862A patent/AU2022202862B2/en active Active
-
2023
- 2023-11-15 JP JP2023194061A patent/JP2024003167A/en active Pending
-
2024
- 2024-04-10 JP JP2024063162A patent/JP2024083529A/en active Pending
- 2024-06-27 AU AU2024204437A patent/AU2024204437A1/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1254895A1 (en) * | 2000-01-20 | 2002-11-06 | Eisai Co., Ltd. | Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
EP1308439A1 (en) * | 2000-08-10 | 2003-05-07 | Welfide Corporation | Proline derivatives and use thereof as drugs |
WO2004056830A1 (en) * | 2002-12-19 | 2004-07-08 | Pfizer Products Inc. | Pyrrolopyrimidine derivatives |
WO2005060947A2 (en) * | 2003-12-19 | 2005-07-07 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
WO2008060621A2 (en) * | 2006-11-17 | 2008-05-22 | Abbott Laboratories | Aminopyrrolidines as chemokine receptor antagonists |
EP2141163A1 (en) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituted thiazolidinones, their production and utilisation as medicine |
WO2011029915A1 (en) * | 2009-09-10 | 2011-03-17 | Novartis Ag | Ether derivatives of bicyclic heteroaryls |
WO2011101409A1 (en) * | 2010-02-19 | 2011-08-25 | Novartis Ag | Pyrrolopyrimidine compounds as inhibitors of cdk4/6 |
EP2878601A1 (en) * | 2012-07-27 | 2015-06-03 | Riken | Agent for treating or controlling recurrence of acute myelogenous leukemia |
WO2014157687A1 (en) * | 2013-03-29 | 2014-10-02 | 大鵬薬品工業株式会社 | 1,2,4-triazine-6-carboxamide derivative with acetamide group |
WO2014174021A1 (en) * | 2013-04-24 | 2014-10-30 | Janssen Pharmaceutica Nv | 3-(2-aminopyrimidin-4-yl)-5-(3-hydroxypropynyl)-1h-pyrrolo[2,3-c]pyridine derivatives as nik inhibitors for the treatment of cancer |
WO2014184069A1 (en) * | 2013-05-14 | 2014-11-20 | Nerviano Medical Sciences S.R.L. | Pyrrolo[2,3-d]pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
WO2015044269A1 (en) * | 2013-09-26 | 2015-04-02 | Janssen Pharmaceutica Nv | NEW 3-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-c]PYRIDINE DERIVATIVES AS NIK INHIBITORS |
WO2016062789A1 (en) * | 2014-10-23 | 2016-04-28 | Janssen Pharmaceutica Nv | New thienopyrimidine derivatives as nik inhibitors |
WO2016062791A1 (en) * | 2014-10-23 | 2016-04-28 | Janssen Pharmaceutica Nv | New pyrazole derivatives as nik inhibitors |
Also Published As
Publication number | Publication date |
---|---|
AU2022202862A1 (en) | 2022-05-19 |
CA3006966A1 (en) | 2017-06-08 |
WO2017096323A1 (en) | 2017-06-08 |
EP3383390A1 (en) | 2018-10-10 |
AU2016365400B2 (en) | 2022-04-07 |
JP2024083529A (en) | 2024-06-21 |
AU2024204437A1 (en) | 2024-07-18 |
JP2024003167A (en) | 2024-01-11 |
AU2016365400C1 (en) | 2022-11-10 |
IL259726A (en) | 2018-07-31 |
JP2018536716A (en) | 2018-12-13 |
JP7011596B2 (en) | 2022-02-10 |
JP2022036285A (en) | 2022-03-04 |
CN108883103A (en) | 2018-11-23 |
AU2016365400A1 (en) | 2018-06-21 |
IL259726B (en) | 2021-10-31 |
KR20180094940A (en) | 2018-08-24 |
AU2022202862B2 (en) | 2024-03-28 |
JP7472175B2 (en) | 2024-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1252163A1 (en) | Receptor | |
EP3523306A4 (en) | Spirocyclic compounds | |
GB201514875D0 (en) | Receptor | |
EP3325449A4 (en) | Compounds | |
EP3248300A4 (en) | Enhanced csi feedback for fd-mimo | |
EP3224246A4 (en) | 4-oxoquinoline compounds | |
EP3099695A4 (en) | Compounds | |
EP3099694A4 (en) | Compounds | |
EP3172208A4 (en) | Compounds | |
IL250888A0 (en) | Substituted piperidine compounds | |
EP3319444A4 (en) | Mu opioid receptor modulators | |
EP3095185A4 (en) | Photovoltaic-clad masonry unit | |
EP3227309A4 (en) | Crystalline difucosyllactose | |
HK1256671A1 (en) | Spirocyclic compounds | |
ZA201606141B (en) | Piperidine derivatives as orexin receptor antagonist | |
EP3110792A4 (en) | Aminocarbonylcarbamate compounds | |
EP3202516A4 (en) | Chuck structure | |
EP3129017A4 (en) | Mitochondria-targeting platinum(iv) prodrug | |
EP3310352A4 (en) | Crystalline compounds | |
EP3152190A4 (en) | 18-20 member bi-polycyclic compounds | |
EP3149010A4 (en) | Monoaminosilane compounds | |
EP3097912A4 (en) | Megalin antagonist | |
IL259726B (en) | Piperidinyl nociceptin receptor compounds | |
EP3350167A4 (en) | Androgen receptor antagonists | |
EP3255044A4 (en) | Diaza-benzofluoranthrene compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180531 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 401/04 20060101AFI20190709BHEP Ipc: A61K 31/44 20060101ALI20190709BHEP Ipc: C07D 471/10 20060101ALI20190709BHEP Ipc: C07D 405/14 20060101ALI20190709BHEP Ipc: C07D 401/14 20060101ALI20190709BHEP Ipc: A61P 29/00 20060101ALI20190709BHEP Ipc: C07D 471/04 20060101ALI20190709BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20191023 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: C07D 405/14 20060101ALI20191017BHEP Ipc: C07D 471/04 20060101ALI20191017BHEP Ipc: C07D 471/10 20060101ALI20191017BHEP Ipc: A61P 29/00 20060101ALI20191017BHEP Ipc: A61K 31/44 20060101ALI20191017BHEP Ipc: C07D 401/14 20060101ALI20191017BHEP Ipc: C07D 401/04 20060101AFI20191017BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1261973 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220510 |